GPT Healthcare
Ticker > Company >

GPT Healthcare share price

GPT Healthcare Ltd.

NSE: GPTHEALTH BSE: 544131 SECTOR: Hospital & Healthcare Services  54.24 K   93   20

156.50
+1.35 (0.87%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 159.95

Today's Low

₹ 154.85

52 Week High

₹ 184.8

52 Week Low

₹ 114

FinStar

Ownership Very Stable
High level of belief in company’s potential exhibited by insiders.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1284.16 Cr.

Enterprise Value

₹ 1295.79 Cr.

No. of Shares

8.21 Cr.

P/E

30.41

P/B

4.77

Face Value

₹ 10

Div. Yield

1.59 %

Book Value (TTM)

₹  32.84

CASH

₹ 4.48 Cr.

DEBT

₹ 16.11 Cr.

Promoter Holding

65.57 %

EPS (TTM)

₹  5.15

Sales Growth

16.08%

ROE

16.32 %

ROCE

23.06%

Profit Growth

-15.43 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year16.08%
3 Year9.39%
5 Year14.25%

Profit Growth

1 Year-15.43%
3 Year2.67%
5 Year14.89%

ROE%

1 Year16.32%
3 Year20.87%
5 Year23.96%

ROCE %

1 Year23.06%
3 Year28.42%
5 Year27.55%

Debt/Equity

0.0598

Price to Cash Flow

15.82

Interest Cover Ratio

7.6508

CFO/PAT (5 Yr. Avg.)

1.58537513067715

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 65.57 0.00
Dec 2025 65.57 0.00
Sep 2025 65.57 0.00
Jun 2025 65.57 0.00
Mar 2025 65.57 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 20.8744333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 28.4225666666667% over the past 3 years.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 20.5431% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -132.8843 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.58537513067715.
  • The company has a high promoter holding of 65.57%.

 Limitations

  • The company has shown a poor profit growth of 2.67342444968659% for the Past 3 years.
  • The company has shown a poor revenue growth of 9.38656964738562% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 101.4 107.11 118.91 120.16 126.37
Total Expenditure 80.71 89.74 96.17 99.45 103
Operating Profit 20.69 17.37 22.74 20.71 23.37
Other Income 1.57 1.56 1.34 1.42 1.63
Interest 1.02 1.63 2.16 2.26 2.18
Depreciation 4.88 6.18 6.85 7.11 6.95
Exceptional Items 0 0 0 0 0
Profit Before Tax 16.37 11.11 15.07 12.76 15.87
Tax 3.48 3.43 4.47 3.39 1.3
Profit After Tax 12.89 7.68 10.6 9.37 14.57
Adjusted EPS (Rs) 1.57 0.94 1.29 1.14 1.78

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 337.42 361.04 400.19 407.09 472.55
Total Expenditure 263.58 286.69 312.35 323.74 388.36
Operating Profit 73.84 74.35 87.84 83.35 84.18
Other Income 4.99 5.69 5.29 8.49 5.95
Interest 11.15 9.16 7.11 3.47 8.24
Depreciation 13.59 14.91 17.98 19.03 27.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 54.08 55.97 68.04 69.35 54.81
Tax 12.42 16.96 20.27 19.42 12.59
Net Profit 41.66 39.01 47.77 49.92 42.22
Adjusted EPS (Rs.) 5.21 4.88 5.82 6.08 5.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 79.9 79.9 82.05 82.05 82.05
Total Reserves 78.28 85.46 136.44 165.8 187.37
Borrowings 72.44 40.27 3.62 5.53 7.16
Other N/C liabilities 20.41 68.95 87.76 80.61 124.83
Current liabilities 68.48 81.84 77.21 74.24 79.49
Total Liabilities 319.51 356.43 387.08 408.23 480.92
Assets
Net Block 220.19 227.85 224.05 227.88 342.25
Capital WIP 0.72 2.61 6.4 46.33 0.71
Intangible WIP 0 0 0 0 0
Investments 5 5.17 19.17 0 0
Loans & Advances 7.78 39.45 57.07 54.69 45.23
Other N/C Assets 0.14 0.08 0.23 0.52 3.45
Current Assets 85.69 81.27 80.16 78.82 89.28
Total Assets 319.51 356.43 387.08 408.23 480.92
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 54.08 55.97 68.04 69.35 54.81
Adjustment 19.95 18.65 21.95 18.74 33.88
Changes in Assets & Liabilities 5.46 2.03 -6.17 -3.61 5.5
Tax Paid -13.49 -10.29 -15.02 -17.08 -13.03
Operating Cash Flow 65.99 66.36 68.8 67.4 81.16
Investing Cash Flow -5.34 5.15 -25.21 -32.59 -47.25
Financing Cash Flow -57.16 -73.18 -48.5 -34.84 -31.43
Net Cash Flow 3.49 -1.67 -4.91 -0.03 2.47

Corporate Actions

Investors Details

PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
promoters 65.57 65.57 65.57 65.57 65.57
gpt sons private limited 65.57 65.57 65.57 65.57 65.57
PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
investors 34.43 34.43 34.43 34.43 34.43
bandhan small cap fund 2.77 2.74 4.64 4.72 4.69
india capital growth fund... 2.68 2.68 2.68 2.68 2.68
llp 0.25 0.47 0.56 0.50 0.71
rajasthan global securiti... 1.20 1.20 1.20 - 1.20
aditya birla sun life ins... 3.50 3.50 - - -
duro one investments limi... 1.01 1.01 - - -
kotak mahindra trustee co... 2.41 1.04 - - -
axis mutual fund trustee ... 1.47 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2026
Annual Report 2025

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY26
Concall Q4FY25
Concall Q4FY24
Concall Q1FY26
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q3FY26
Presentation Q3FY24

Company News

 No Latest News available for this company.Report us

GPT Healthcare Stock Price Analysis and Quick Research Report. Is GPT Healthcare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse GPT Healthcare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). GPT Healthcare has a PE ratio of 30.4635118064328 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. GPT Healthcare has ROA of 9.4968% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. GPT Healthcare has a Current ratio of 1.1231.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. GPT Healthcare has a ROE of 16.3241%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. GPT Healthcare has a Debt to Equity ratio of 0.0598 which means that the company has low proportion of debt in its capital.

  • Sales growth: GPT Healthcare has reported revenue growth of 16.0788% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of GPT Healthcare for the current financial year is 17.8147358887052%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for GPT Healthcare is Rs 2.5 and the yield is 1.5929%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of GPT Healthcare is Rs 5.1455. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of GPT Healthcare in Ticker for free. Also, one can get the intrinsic value of GPT Healthcare by using Valuation Calculators, which are available with a Finology ONE subscription. 

GPT Healthcare FAQs

Q1. What is GPT Healthcare share price today?
Ans: The current share price of GPT Healthcare is Rs 156.75.

Q2. What is the market capitalisation of GPT Healthcare?
Ans: GPT Healthcare has a market capitalisation of Rs 1286.209350525 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of GPT Healthcare?
Ans: The PE ratio of GPT Healthcare is 30.4635118064328 and the P/B ratio of GPT Healthcare is 4.77385480781237, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of GPT Healthcare share?
Ans: The 52-week high share price of GPT Healthcare is Rs 185, and the 52-week low share price of GPT Healthcare is Rs 115.

Q5. Does GPT Healthcare pay dividends?
Ans: Currently, GPT Healthcare pays dividends. Dividend yield of GPT Healthcare is around 1.5929%.

Q6. What are the face value and book value of GPT Healthcare shares?
Ans: The face value of GPT Healthcare shares is Rs 10, while the book value per share of GPT Healthcare is around Rs 32.8351. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of GPT Healthcare?
Ans: GPT Healthcare has a total debt of Rs 16.1099 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of GPT Healthcare?
Ans: The ROE of GPT Healthcare is 16.3241% and ROCE of GPT Healthcare is 23.0647%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is GPT Healthcare a good buy for the long term?
Ans: The GPT Healthcare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is GPT Healthcare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the GPT Healthcare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check GPT Healthcare’s financials?
Ans: You can review GPT Healthcare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about GPT Healthcare
X